![Cancer drugs' share of new FDA approvals doubled this decade thanks to smarter R&D: report | Fierce Pharma Cancer drugs' share of new FDA approvals doubled this decade thanks to smarter R&D: report | Fierce Pharma](https://qtxasset.com/cdn-cgi/image/w=384,h=216,f=auto,fit=crop,g=0.5x0.5/https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1567603608/Cancer_PDPics_Pixabay.jpg/Cancer_PDPics_Pixabay.jpg?VersionId=iHZUJw4NIk0zDniDv2jxUgq6O36.bBIE)
Cancer drugs' share of new FDA approvals doubled this decade thanks to smarter R&D: report | Fierce Pharma
![Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study - The Lancet Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study - The Lancet](https://www.thelancet.com/cms/attachment/16011888-c55b-4d8c-b79d-188667083b33/gr1_lrg.jpg)
Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study - The Lancet
![JPM | Free Full-Text | Predictive Values of Preoperative Characteristics for 30-Day Mortality in Traumatic Hip Fracture Patients | HTML JPM | Free Full-Text | Predictive Values of Preoperative Characteristics for 30-Day Mortality in Traumatic Hip Fracture Patients | HTML](https://www.mdpi.com/jpm/jpm-11-00353/article_deploy/html/images/jpm-11-00353-g003.png)
JPM | Free Full-Text | Predictive Values of Preoperative Characteristics for 30-Day Mortality in Traumatic Hip Fracture Patients | HTML
![2022 UCLA Hollywood TV Diversity Report Finds “Progress” For Women & Minorities, But Latinos Still Lag – Deadline 2022 UCLA Hollywood TV Diversity Report Finds “Progress” For Women & Minorities, But Latinos Still Lag – Deadline](https://deadline.com/wp-content/uploads/2022/10/Show-Creators-By-Gender-UCLA.jpg?w=1024)